Spots Global Cancer Trial Database for lymph node
Every month we try and update this database with for lymph node cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Fluorescein for Lymphatic Mapping and Sentinel Lymph Node (SLN) Biopsy in Patients With Stage I and II Malignant Melanoma | NCT00847522 | Cancer | Fluorescein | 18 Years - | University of Utah | |
Fluorescein for Lymphatic Mapping and Sentinel Lymph Node (SLN) Biopsy in Patients With Stage I and II Malignant Melanoma | NCT00847522 | Cancer | Fluorescein | 18 Years - | University of Utah | |
Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer | NCT06121557 | Breast Neoplasm... | Surgery for har... Cyclophosphamid... Fludarabine Tumor-draining ... Interleukin-2 Camrelizumab Chemotherapeuti... | 18 Years - 70 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
NIR-Guided Sentinel Lymph Node Mapping in Melanoma | NCT01121718 | Melanoma | ICG Interventio... | 18 Years - | Dana-Farber Cancer Institute | |
Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers | NCT02141490 | Prostate Cancer Bladder Cancer Kidney Cancer | Ferumoxytol Magnetic Resona... | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer | NCT06121570 | Breast Neoplasm... | Sentinel Lymph ... Doxorubicin Epirubicin Cyclophosphamid... Cyclophosphamid... Fludarabine Tumor-draining ... Interleukin-2 Nab-paclitaxel | 18 Years - 70 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
Significance of Ultrasound Elastography in Lymph Node | NCT03391557 | Lung Cancer | UE | 27 Years - 81 Years | Nanjing First Hospital, Nanjing Medical University | |
CT-based Radiomics of ALN pCR (ypN0) in Breast Cancer Undergoing NAC | NCT04457700 | Triple-negative... HER2-positive B... | 18 Years - 70 Years | Peking University | ||
Ex Vivo-Activated Lymph Node Lymphocytes in Treating Patients With Stage IIIC-IV Melanoma | NCT02327390 | Stage IIIC Skin... Stage IV Melano... | lymph node X-ACT | 18 Years - | Case Comprehensive Cancer Center | |
Utility of Endobronchial Ultrasound Guided Needle Biopsy in Early Stage Non- Small Cell Lung Cancer (NSCLC) | NCT00832715 | Lung Cancer | EBUS-TBNA | 18 Years - | M.D. Anderson Cancer Center | |
Ex-vivo Sentinel Lymph Node in Stage I-II Colon Cancer: Kappa Analysis With Immunochemistry and Molecular Biology | NCT02861430 | Colon Cancer Lymph Node Sentinel Node | Immunochemistry... | 18 Years - | Centre Hospitalier Universitaire de Besancon | |
UNN-RADS Scale for Diagnosing Lymph Node Metastasis in Patients With History of Thyroid Cancer | NCT06124469 | Thyroid Cancer Lymph Node | US-guided fine ... | 18 Years - 64 Years | Instituto Mexicano del Seguro Social | |
Hysteroscopic Lymphatic Mapping for Endometrial Cancer | NCT00671606 | Endometrial Can... | Intraoperative ... | - | M.D. Anderson Cancer Center | |
Fluorescein for Lymphatic Mapping and Sentinel Lymph Node (SLN) Biopsy in Patients With Stage I and II Malignant Melanoma | NCT00847522 | Cancer | Fluorescein | 18 Years - | University of Utah | |
Combining MRI and CEUS to Diagnose Small Cervical Lymph Node Metastases in NPC Patients | NCT05389306 | Nasopharyngeal ... | MRI Scanning Contrast-Enhanc... Ultrasound-guid... | 18 Years - 70 Years | Sun Yat-sen University | |
CK19 Combined With Contrast-enhanced Ultrasound: a Prediction System on Axillary Lymph Node Metastasis in Breast Cancer | NCT02992067 | Lymph Node Breastcancer | 18 Years - 70 Years | Zhejiang Cancer Hospital | ||
Ex Vivo Intra-arterial Indigo Carmine Injection After Transanal Total Mesorectal Excision | NCT04455737 | Rectal Neoplasm... | injection of in... | 18 Years - | Cantonal Hospital of St. Gallen | |
Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers | NCT02141490 | Prostate Cancer Bladder Cancer Kidney Cancer | Ferumoxytol Magnetic Resona... | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer | NCT06121557 | Breast Neoplasm... | Surgery for har... Cyclophosphamid... Fludarabine Tumor-draining ... Interleukin-2 Camrelizumab Chemotherapeuti... | 18 Years - 70 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
UNN-RADS Scale for Diagnosing Lymph Node Metastasis in Patients With History of Thyroid Cancer | NCT06124469 | Thyroid Cancer Lymph Node | US-guided fine ... | 18 Years - 64 Years | Instituto Mexicano del Seguro Social | |
CK19 Combined With Contrast-enhanced Ultrasound: a Prediction System on Axillary Lymph Node Metastasis in Breast Cancer | NCT02992067 | Lymph Node Breastcancer | 18 Years - 70 Years | Zhejiang Cancer Hospital | ||
Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer | NCT06121570 | Breast Neoplasm... | Sentinel Lymph ... Doxorubicin Epirubicin Cyclophosphamid... Cyclophosphamid... Fludarabine Tumor-draining ... Interleukin-2 Nab-paclitaxel | 18 Years - 70 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer | NCT05981001 | Breast Neoplasm... | Surgery for har... Cyclophosphamid... Fludarabine Tumor-draining ... Interleukin-2 Camrelizumab Nab-paclitaxel Gemcitabine Carboplatin | 18 Years - 70 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
UNN-RADS Scale for Diagnosing Lymph Node Metastasis in Patients With History of Thyroid Cancer | NCT06124469 | Thyroid Cancer Lymph Node | US-guided fine ... | 18 Years - 64 Years | Instituto Mexicano del Seguro Social | |
Ex Vivo-Activated Lymph Node Lymphocytes in Treating Patients With Stage IIIC-IV Melanoma | NCT02327390 | Stage IIIC Skin... Stage IV Melano... | lymph node X-ACT | 18 Years - | Case Comprehensive Cancer Center | |
Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer | NCT05981001 | Breast Neoplasm... | Surgery for har... Cyclophosphamid... Fludarabine Tumor-draining ... Interleukin-2 Camrelizumab Nab-paclitaxel Gemcitabine Carboplatin | 18 Years - 70 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
Detection of Micrometastases in Lymph Nodes of Patients With Prostate Cancer | NCT01615965 | Prostate Cancer | tumor marker de... | 18 Years - 80 Years | Technical University of Munich | |
Benign-Malign Differentiation of Axillary Lymph Nodes: The Role Of Superb Microvascular Imaging | NCT05927727 | Diagnosis Axilla; Breast | Ultrasound and ... | 18 Years - 74 Years | Ankara Education and Research Hospital | |
Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer | NCT05981001 | Breast Neoplasm... | Surgery for har... Cyclophosphamid... Fludarabine Tumor-draining ... Interleukin-2 Camrelizumab Nab-paclitaxel Gemcitabine Carboplatin | 18 Years - 70 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
Prediction of Lymph Node Invasion for Prostate Adenocarcinoma | NCT04909957 | Adenocarcinoma ... | 18 Years - | University Hospital, Brest | ||
Hysteroscopic Lymphatic Mapping for Endometrial Cancer | NCT00671606 | Endometrial Can... | Intraoperative ... | - | M.D. Anderson Cancer Center |